Prosecution Insights
Last updated: August 18, 2026

Examiner: ZEMAN, ROBERT A

Tech Center 1700 • Art Units: 1645 1792

This examiner grants 54% of resolved cases

Performance Statistics

54.0%
Allow Rate
-11.0% vs TC avg
838
Total Applications
+27.9%
Interview Lift
1343
Avg Prosecution Days
Based on 780 resolved cases, 2023–2026

Rejection Statute Breakdown

6.1%
§101 Eligibility
16.6%
§102 Novelty
23.0%
§103 Obviousness
44.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18484980 STREPTOCOCCUS THERMOPHILUS STARTER STRAIN Non-Final OA DSM IP Assets B.V.
18531938 METHOD TO PROVIDE LONG-LASTING CLEANING Final Rejection The Procter & Gamble Company
18322442 METHODS FOR DIAGNOSING GASTRIC INTESTINAL METAPLASIA Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18272540 METHOD AND KIT FOR DETECTING PRESENCE AND/OR AMOUNT OF BACTERIA OF ENTEROBACTERIACEAE IN FOOD/DRINK SAMPLE, ENVIRONMENTAL SAMPLE, OR BIOLOGICAL SAMPLE Non-Final OA ASAHI KASEI KABUSHIKI KAISHA
17780239 NOVEL SERINE PROTEASE VARIANT Non-Final OA CJ CHEILJEDANG CORPORATION
18270611 METHODS AND COMPOSITION FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER Final Rejection The General Hospital Corporation
18438870 MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES Non-Final OA GLAXOSMITHKLINE BIOLOGICALS SA
18693672 INNOVATIVE BIOTECHNOLOGICAL SYSTEMS FOR THE DETECTION OF CELLULAR OR MOLECULAR ANALYTES Non-Final OA ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month